The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site. Please see our Subscription Terms and Conditions.

All material subject to strictly enforced copyright laws. © 2022 Euromoney, a part of the Euromoney Institutional Investor PLC.

Foreign investors still hungry for convertibles


Foreign investors still appear to have an appetite for Indian foreign currency convertible bonds. Several Indian FCCBs issued early this year are trading at a discount in the secondary market. A $100 million convertible bond offering by Indian pharmaceutical company Wockhardt received a healthy response from European and offshore US hedge fund investors in mid-September. Around the same time, another Indian company, Sterling Biotech, sold $70 million of convertibles and four others – Sun Pharmaceuticals, Larsen & Toubro, United Phosporous and Orchid Chemicals – could come to market later this year.

The five-year Wockhardt bonds were priced with a coupon/yield to maturity of 5.25% and a conversion premium of around 50% to the company's share price in the local market. The company exercised the $10 million greenshoe option and the bonds will be listed in Hong Kong.

One of the largest Indian exporters of generic bulk drugs, Wockhardt plans to use the cash to acquire companies in Europe, its largest market. In May this year it acquired German company Esparma for $11 million, the company's third foreign acquisition after UK-based CP Pharmaceuticals last year and Wallis Laboratory in 1998.

Record issuance

Last year's spectacular rise in Indian equity prices, the Indian government's decision to ease restrictions on foreign currency borrowing by Indian companies in January and a Moody's upgrade to investment grade for Indian foreign currency debt has led to record issuance of convertibles by Indian companies.

You have reached premium content. Please log in to continue reading.

Read beyond the headlines with Euromoney

For over 50 years, our readers have looked to Euromoney to stay informed about the issues that matter in the international banking and financial markets. Find out more about our different levels of access below.


Unlimited access to and

Expert comment, long reads and in-depth analysis interviews with senior finance professionals

Access the results of our market-leading annual surveys across core financial services

Access the results of our annual awards, including the world-renowned Awards for Excellence

Your print copy of Euromoney magazine delivered monthly

£73.75 per month

Billed Annually


Unlimited access to and, including our top stories, long reads, expert analysis, and the results of our annual surveys and awards

Sign up to any of our newsletters, curated by our editors


Already a user?

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree